Genentech Settles Stockholder Suits: The South San...
- Share via
From Times Staff and Wire Reports
Genentech Settles Stockholder Suits: The South San Francisco genetic engineering company said it paid $29 million to settle all class-action suits brought against it in 1988. The suits alleged that company actions artificially inflated the stock price. Genentech, which made no admission of guilt, said the settlement would be covered by insurance and a reserve fund and would not materially affect fourth-quarter earnings.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
